COVID-19 and the management of thoracic cancer patients: challenges and recommendations

Jan Van Meerbeeck (Antwerp, Belgium), Isabelle Opitz (Zurich, CH), Matthias Guckenberger (Zurich, CH), Jo Raskin (Antwerp, Belgium)

Source: ERS webinar 2020: COVID-19 and the management of thoracic cancer patients: challenges and recommendations
Number: 0

WebcastSlide presentation

Rating: 4.5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Jan Van Meerbeeck (Antwerp, Belgium), Isabelle Opitz (Zurich, CH), Matthias Guckenberger (Zurich, CH), Jo Raskin (Antwerp, Belgium). COVID-19 and the management of thoracic cancer patients: challenges and recommendations. ERS webinar 2020: COVID-19 and the management of thoracic cancer patients: challenges and recommendations

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Year: 2006

Delays in lung cancer management
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005


Direct to surgery treatment of suspected lung cancer – results from a UK lung cancer multidisciplinary team (MDT)
Source: Virtual Congress 2021 – Innovation in thoracic surgery
Year: 2021



Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019


Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy
Source: Eur Respir J 2012; 39: 1437-1442
Year: 2012



Lung cancer: the importance of seeing a respiratory physician
Source: Eur Respir J 2003; 21: 606-610
Year: 2003



Lung cancer in COPD
Source: Eur Respir Mon 2013; 59: 174-188
Year: 2013


Challenges in the management of SCLC Part 2: Extensive disease, prophylaxis/treatment of brain metastases
Source: ERS webinar 2021: Challenges in the management of SCLC Part 2: Extensive disease, prophylaxis/treatment of brain metastases
Year: 2021


The need for early MDT assessment of lung cancer patients presenting with pain
Source: Eur Respir J 2003; 22: Suppl. 45, 432s
Year: 2003

The evaluation of lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 323s
Year: 2005

Lung cancer: does age affect treatment strategy?
Source: Eur Respir Mon; 2009: 43:306–326
Year: 2009

Challenges in molecular testing in lung cancer patients with advanced disease
Source: International Congress 2016 – Lung cancer: latest developments in screening and patient management
Year: 2016


Missed lung cancer on chest radiography – does it affect the outcome?
Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques
Year: 2007



Efficacy of a pulmonary rehabilitation programme (PRP) after lung resection (LR) for cancer
Source: Annual Congress 2005 - Pulmonary rehabilitation: an evidence-based intervention
Year: 2005


Chemotherapy for small cell lung cancer
Source: Annual Congress 2006 - PG12 - Small cell lung cancer management
Year: 2006


The approach to the surgical management of cancer in four European countries
Source: Eur Respir J 2003; 22: 838-844
Year: 2003



Biomarkers for non-small cell lung cancer (NSCLC) treatment: examples and unmet needs, a clinical perspective
Source: International Congress 2014 – From bench to bedside: biomarkers and biobanking for lung cancer in 2014
Year: 2014



New and anticipated therapeutic developments in management of non-small-cell lung cancer
Source: Annual Congress 2013 –ERS/The Lancet/The Lancet Respiratory Medicine joint Lunchtime session on lung cancer
Year: 2013